Source:http://linkedlifedata.com/resource/pubmed/id/17053291
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-3-26
|
pubmed:abstractText |
The relation between the incidence of methimazole (methylmercaptoimidazole; MMI)-induced agranulocytosis and initial MMI dose was evaluated in a group of 514 patients with Graves' disease who were treated between 1995 and 2005. One hundred and forty-six (28.40%) patients had received an initial dose of 30 mg MMI and 277 (53.89%) patients had been treated with 15 mg MMI. Nine patients (1.75%) developed agranulocytosis due to MMI treatment. Six (4.11%) of 146 patients who received an initial dose of 30 mg MMI, two (4.54%) of 44 patients given an initial dose of 20 mg MMI, and one (0.36%) of 277 patients given an initial dose of 15 mg MMI developed agranulocytosis. There was a statistically significant difference in agranulocytosis incidence between patients receiving an initial dose of 30 mg MMI and those who received an initial dose of 15 mg. Although 8 (4.10%) of 195 patients in the high-dose group (20 mg or higher) developed agranulocytosis, only 1 (0.31%) of 319 patients in the low-dose group (15 mg or lower) did. In conclusion, the incidence of agranulocytosis with low-dose MMI therapy was ten times lower than that of the high-dose regimen.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0918-8959
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-43
|
pubmed:meshHeading |
pubmed-meshheading:17053291-Adolescent,
pubmed-meshheading:17053291-Adult,
pubmed-meshheading:17053291-Agranulocytosis,
pubmed-meshheading:17053291-Antithyroid Agents,
pubmed-meshheading:17053291-Dose-Response Relationship, Drug,
pubmed-meshheading:17053291-Female,
pubmed-meshheading:17053291-Graves Disease,
pubmed-meshheading:17053291-Humans,
pubmed-meshheading:17053291-Incidence,
pubmed-meshheading:17053291-Male,
pubmed-meshheading:17053291-Methimazole,
pubmed-meshheading:17053291-Middle Aged,
pubmed-meshheading:17053291-Retrospective Studies
|
pubmed:year |
2007
|
pubmed:articleTitle |
The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
|
pubmed:affiliation |
Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|